Our aim to make use of cell-based and physical methods to load both mammalian and bacterial extracellular vesicles with nucleic acid cargo for gene therapies and vaccine applications. We have developed a transgenic system that when transfected into mammalian cells allows for endogenous loading of miRNA into extracellular vesicles, while exploring physical methods to load plasmid DNA into bacterial outer membrane vesicles as an oral delivery platform.